Illness	Number of cases
Essential primary hypertension (I10.01)	96
Volume depletion (E86)	83
Left ventricular failure unspecified (I50.14)	75
Gastritis and duodenitis (K29.1)	63
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	57
Heart failure (I50.01)	51
Dorsalgia - Pain in thoracic spine (M54.6)	43
Pneumonia organism unspecified - Other pneumonia unspecified organism (J18.8)	40
Viral pneumonia not elsewhere classified (J12.8)	38
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	36

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	620
Quantitative analysis of specific values such as organ function or blood flow rate (3-993)	497
Anaesthesia with administration of an anaesthetic into a vein (8-900)	451
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	293
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	249
(9-984.7)	232
(9-984.8)	224
(9-984.b)	178
(9-984.9)	108
Examination of the large intestine by endoscopy - colonoscopy (1-650.1)	103

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
11	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
11	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
11	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility